BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tomie A, Yoshida N, Kugai M, Hirose R, Dohi O, Inoue K, Okuda K, Motoyoshi T, Fukumoto K, Inagaki Y, Yoriki H, Inada Y, Okuda T, Hasegawa D, Ogiso K, Murakami T, Soga K, Rani RA, Yoshida N, Itoh Y. The Efficacy and Safety of Elobixibat for the Elderly with Chronic Constipation: A Multicenter Retrospective Cohort Study. Gastroenterol Res Pract 2020;2020:9656040. [PMID: 32411210 DOI: 10.1155/2020/9656040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Matsuyama M, Hirai K, Nonaka H, Ueda M, Morino J, Kaneko S, Minato S, Mutsuyoshi Y, Yanai K, Ishii H, Kitano T, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y. Effects of Elobixibat on Constipation and Lipid Metabolism in Patients With Moderate to End-Stage Chronic Kidney Disease. Front Med 2022;8:780127. [DOI: 10.3389/fmed.2021.780127] [Reference Citation Analysis]
2 Ooba N, Takahashi Y, Nagamura M, Takahashi M, Ushida M, Kawakami E, Kimura M, Sato T, Tokuyoshi J, Miyazaki C, Shimada M. Safety of elobixibat and lubiprostone in Japanese patients with chronic constipation: a retrospective cohort study. Expert Opin Drug Saf 2021;:1-6. [PMID: 34281471 DOI: 10.1080/14740338.2021.1952980] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Włodarczyk J, Waśniewska A, Fichna J, Dziki A, Dziki Ł, Włodarczyk M. Current Overview on Clinical Management of Chronic Constipation. J Clin Med 2021;10:1738. [PMID: 33923772 DOI: 10.3390/jcm10081738] [Reference Citation Analysis]